Archives | Subscribe | Printer-Friendly | Advertise | Send to a Friend | cmsa.org July 6, 2016
   
V.A.C. Therapy
KCI V.A.C.® NEGATIVE PRESSURE WOUND THERAPY MEDICARE PART B REIMBURSEMENT FACTS:
  • V.A.C.® Therapy is still available to patients
  • V.A.C.® Therapy did not lose Medicare coverage
  • KCI is working with contracted suppliers to provide V.A.C.® Therapy for patients served in CMS Round 2 recompete competitive bidding areas (CBAs)
 style=
To learn the facts, contact your Acelity representative or visit npwtcompetitivebidding.com for an on-demand webinar.
Webinar date and time: July 14, 2016 at 12:00 PM EST and 3:00 PM EST
Who should attend? WOCNs, Case Managers, Social Workers, Discharge Planners, and any healthcare professional involved with ordering or transitioning patients to the home care setting.
 style=
 style=
FROM HOSPITAL TO HOME, CLINICIANS ARE CONFIDENT IN THE CERTAINTY OF ACELITY™.
10 million wounds treated worldwide with V.A.C.® Therapy*
SENSAT R.A.C. Technology with EasyClear™ Purge Technology, demonstrates Acelity's industry leadership
Over 158,000 Medicare Patients** since competitive bidding was implemented in 2013
95% of Published NPWT Clinical Evidence is based on V.A.C.® Therapy**
400 Clinically Trained Representatives support therapy outcomes
Dedicated Team of 65 Nurses monitor patient progress
The Certainty of Acelity™
*As of June 2016, KCI data on file.
**KCI data on file.
   
The leading membership association providing professional
collaboration across the health care continuum.


5034A Thoroughbred Lane | Brentwood, TN 37027 | Phone: (615) 432-0101 | Toll-Free: (800) 216-2672 | Fax: 615.523.1715
Email: cmsa@cmsa.org | Website: www.cmsa.org

We would appreciate your comments or suggestions. Your email will be kept private and confidential.